Skip to main content

1 Result(s)

within Takanori Yoshikawa Remove this filter Immunology Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors

    While PD-1/L1 inhibitors are characterized by durable tumor control, they also prolong survival without prolongation of progression-free survival (PFS) in part of patients. However, little is known about the f...

    Yuhei Harutani, Yuichi Ozawa, Eriko Murakami… in Cancer Immunology, Immunotherapy (2022)